{"id":"https://openalex.org/W93393158","doi":null,"title":"A review of new atypical antipsychotic launches in the United States.","display_name":"A review of new atypical antipsychotic launches in the United States.","publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W93393158","mag":"93393158","pmid":"https://pubmed.ncbi.nlm.nih.gov/21274390","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3028460"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3028460","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3028460","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry (Edgmont)","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3028460","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042554701","display_name":"Jeffrey Ventimiglia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]},{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jeff Ventimiglia","raw_affiliation_strings":["Mr. Ventimiglia is a Senior Analyst in Clinical Development Services, Quintiles, Inc., Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mr. Ventimiglia is a Senior Analyst in Clinical Development Services, Quintiles, Inc., Durham, North Carolina","institution_ids":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006443278","display_name":"Amir H Kalali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amir H Kalali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013970045","display_name":"Leslie Citrome","orcid":"https://orcid.org/0000-0002-6098-9266","observed_orcids":["https://orcid.org/0000-0002-6098-9266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leslie Citrome","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0654,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.89598389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"7","issue":"12","first_page":"13","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.03060000017285347,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asenapine","display_name":"asenapine","score":0.8999999761581421},{"id":"https://openalex.org/keywords/iloperidone","display_name":"iloperidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.996999979019165},{"id":"https://openalex.org/keywords/new-drug-launches","display_name":"new drug introduction","score":0.6740000247955322},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.6100000143051147},{"id":"https://openalex.org/keywords/market-share","display_name":"market share","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C2779626651","wikidata":"https://www.wikidata.org/wiki/Q416545","display_name":"Asenapine","level":4,"score":0.9957987070083618},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7810156345367432},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4447322189807892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39868032932281494},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2975078225135803},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2844502031803131},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.23404008150100708}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:3028460","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3028460","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry (Edgmont)","raw_type":"Text"},{"id":"pmid:21274390","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21274390","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry (Edgmont (Pa. : Township))","raw_type":"Journal Article"},{"id":"mag:93393158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21274390","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3028460","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3028460","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry (Edgmont)","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1839220452","https://openalex.org/W2021096501","https://openalex.org/W2043310433","https://openalex.org/W2059616402","https://openalex.org/W2060003069","https://openalex.org/W2086764077"],"related_works":["https://openalex.org/W200450439","https://openalex.org/W1969050306","https://openalex.org/W2085168171","https://openalex.org/W2359306228","https://openalex.org/W2316454641","https://openalex.org/W2052959946","https://openalex.org/W2129692765","https://openalex.org/W2605315928","https://openalex.org/W2048366685","https://openalex.org/W7125683754"],"abstract_inverted_index":{"In":[0,40],"this":[1],"article":[2],"we":[3],"investigate":[4],"the":[5,29,41,46,51,55,68],"post-launch":[6],"retail":[7],"prescription":[8,70],"trends":[9],"of":[10,67,103],"asenapine":[11,47,58,91,98],"(Saphris(\u00ae),":[12],"Merck":[13],"and":[14,16,36,49,59,64,92],"Co.)":[15],"iloperidone":[17,56,60],"(Fanapt(\u00ae),":[18],"Vanda":[19],"Pharmaceuticals":[20],"Inc./Novartis),":[21],"two":[22],"new":[23,86],"atypical":[24],"antipsychotics":[25],"to":[26,85,107,115],"launch":[27],"in":[28,33,50,110],"United":[30],"States":[31],"market":[32],"October":[34],"2009":[35],"January":[37],"2010,":[38],"respectively.":[39],"first":[42],"12":[43],"months":[44,53],"following":[45],"launch,":[48,57,97],"nine":[52],"since":[54],"have":[61],"secured":[62],"0.22":[63],"0.10":[65],"percent":[66],"total":[69,81],"market;":[71],"however,":[72],"both":[73],"products":[74],"nearly":[75],"double":[76],"those":[77],"respective":[78],"shares":[79],"when":[80],"prescriptions":[82,88],"are":[83],"isolated":[84],"patient":[87],"(0.44%":[89],"for":[90,94],"0.17%":[93],"iloperidone).":[95],"Since":[96],"has":[99],"shown":[100],"stronger":[101],"signs":[102],"growth,":[104],"largely":[105],"attributed":[106],"its":[108],"approval":[109],"multiple":[111],"indications":[112],"as":[113],"compared":[114],"iloperidone's":[116],"single":[117],"indication.":[118]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}